Pharma-Bio Serv, Inc. PBSV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 93.05% | 144.23% | 287.06% | -100.62% | 33.93% |
| Total Depreciation and Amortization | -76.50% | -77.63% | -12.99% | 27.31% | 31.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.59% | -80.38% | 35.72% | 295.34% | -28.25% |
| Change in Net Operating Assets | -76.85% | -23.06% | -6.55% | 398.25% | 231.74% |
| Cash from Operations | -74.25% | -21.12% | 9.17% | 256.76% | 135.28% |
| Capital Expenditure | 30.00% | 46.51% | -- | 99.75% | -5.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -119.92% | 41.51% | 179.49% | -360.67% | -55.83% |
| Cash from Investing | -120.03% | 41.52% | 179.95% | -599.53% | -55.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 95.93% | -- | -- | -194.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.13% | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1.09% | -- | -- | -194.12% |
| Foreign Exchange rate Adjustments | -275.00% | -102.72% | 149.74% | 375.00% | 161.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.65% | 23.82% | 341.72% | -334.02% | -38.07% |